基本信息
views: 148
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Formation
1982: Kantonsschule Freudenberg Zürich, Matura B, 1988
1988: Study of Medicine, University of Zürich, Master’s degree MF Zürich, 1995
1996: Swiss Institute for Experimental Cancer Research, Epalinges, Prof. S. Gasser
1997: MD Thesis: Neuroendocrine Tumors of GIT and Lungs, Prof. P. Heitz
1999: Resident Division Pathology, University Hospital Genève, Prof. B. Borisch
2001: Resident Institute of Pathology, Cantonal Hospital Baden, Prof. P. Komminoth
2004: Resident Department of Surgery, Cantonal Hospital Baden, Prof. T. Kocher
2005: Resident Institute of Pathology, University Hospital Zürich, Prof. H. Moch
2006: Swiss Board in Clinical Pathology
2009: Visiting fellow Histopathology, Royal Brompton London, Prof. A. Nicholson
2011: Venia legendi UZH: Epithelial-Mesenchymal Transition in Thoracic Malignancies
2013: Assistant Professor UZH and Head of Laboratory for In-situ Technologies
2018: Certificate of Advanced Studies in Medical Leadership UZH
2019: Chief Physician, ADMED Pathology Neuchâtel
2020: Titular Professor UZH: Tumorpathology and Biomarkers
2022: Consultant Pathologie Länggasse, Ittigen
Diagnostic expertise
At USZ, I did general histopathology including frozen section, autopsies and liver transplantation pathology. Responsible physician for thoracic pathology, including pleura and mediastinal tumors, lung parenchymal diseases, SILAG lung dust analysis and lung transplantation. Secondary focus on head neck, maxillo-facial and dental pathology. At Neuchâtel, I was doing general histopathology with focus on thoracic pathology as well as autopsies. At Pathologie Länggasse, I am doing gastro-intestinal and pathology including pancreas and liver as well as lympho-haemato and soft tissue pathology.
Research expertise
To search for new biomarkers of lung cancer by proteomics, I originally performed an N-glycoprotein capturing of lung adenocarcinoma malignant pleural effusions followed by liquid chromatography and tandem mass spectrometry. I identified the prognostic epithelial-mesenchymal transition protein periostin, which is upregulated at the invasion front of various tumors in both stroma and tumor epithelia, thereby also associated with vessel infiltration. I validated this prognosticator by immunohistochemistry on a tumor tissue microarray from non-small cell lung carcinoma patients. Mass spectrometry of protein extracts from formalin-fixed paraffin-embedded lung squamous cell carcinomas later showed again the prognostically relevant correlation of periostin with tumor fragmentation and budding, respectively.
Research contributions
I have published 119 original publications, 8 case reports, 13 reviews and 5 book chapters. My own impact factor (first/last author) is 128 with a citation index of 845. My maximal impact factor is 10, my maximal citation index 215. I published in J Thorac Oncol, Cancer Res, Clin Cancer Res, Am J Pathol, Mod Pathol, Am J Surg Pathol and Lung Cancer. The total impact factor of all publications is 640 with a citation index of >7500 and an H-index of 43.
Supervision
PhD Thesis: L. Morra 2011 ETHZ. R. Casanova 2017 UZH. CG. Wu, U. Rulle 2019 UZH
MD Master: MA. Wulf 2012. T. Eichmüller, M. Diebold, M. Haberecker 2015. J. Akeret 2016. K. Ipekciler 2018 UZH
MD Thesis: S. Arbogast, A. Atanassoff, C. Steinmann 2011. L. Frischknecht 2013. M. Mattle 2015. P. Leisibach 2016. M. Diebold 2017. A. Grosse 2020 UZH
Awards
2003: European Helicobacter Study Group, Stockholm, S: First poster prize
2004: Swiss Society of Pathology, Geneva, CH: Rodger C. Haggitt prize
2011: Swiss Society of Pathology, Luzern, CH: Poster prize to V. Tischler
2013: Swiss Society of Cytology, Flims, CH: Second poster prize to V. Tischler
2013: Theiler-Haag Foundation, USZ, CH: Research prize to V. Tischler
2013: Congress Pulmonary Pathology Society, Grenoble, F: First prize Case Contest
2013: University of Zürich, CH: Semester prize to A. Wulf
2014: German Society of Pathology, Berlin, DE: Prize for best research talk
2017: PhD Retreat Cancer Network, Emmetten, CH: Poster prize to K. Silina
2017: German Society of Pathology, Erlangen, DE: Prize for best research talk
2019: Czech Society Pathology, Olomouc, CZ: Best publication to M. Gachechiladze
2019: Swiss Society of Pathology, Luzern, CH: Poster prize to CG. Wu
Own grants
1996: SNSF Postgraduate Course in Experimental Medicine and Biology
2001: Fondation Dinu Lipatti, Geneva
2009: Fondation Nuovo Soldati, Geneva, to V. Tischler
2012: Start-up Fund Clinical Trials Center, USZ/UZH. DFL-1225
2013: Swiss Cancer League. F-87701-31-01
2013: SystemsX Initiative, SNSF. M-87704-01-02
2014: Innovationpool USZ to V. Tischler, USZ
2016: Chinese Scholarship Council to CG. Wu, 4-year PhD formation
2017: Swiss Federal Commission of Technology and Innovation. 25736.1 PFLS-LS
2019: Foundation for Applied Cancer Research, USZ
Memberships
Swiss Society of Pathology, Swiss Lung Pathology Group, German Society of Pathology, European Society of Pathology
Research Interests
Papers共 285 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgeryno. 6 (2024)
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Incno. 12 (2023): 100335-100335
crossref(2023)
crossref(2023)
R. S. Werner,H. Moch, M. Weller, T. Weiss,L. Regli,E. Le Rhun,A. Curioni-Fontecedro,I. Opitz,A. Soltermann
Journal of Thoracic Oncologyno. 11 (2023): S86-S87
NATURE COMMUNICATIONSno. 1 (2023): 5154-5154
crossref(2023)
crossref(2023)
crossref(2023)
Load More
Author Statistics
#Papers: 291
#Citation: 11233
H-Index: 50
G-Index: 104
Sociability: 8
Diversity: 3
Activity: 8
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn